Metabolome analysis of genus Forsythia related constituents in Forsythia suspensa leaves and fruits using UPLC-ESI-QQQ-MS/MS technique.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
06
2021
accepted:
31
05
2022
entrez:
28
6
2022
pubmed:
29
6
2022
medline:
1
7
2022
Statut:
epublish
Résumé
Forsythia suspensa is a traditional Chinese herb. Its numerous metabolites have important roles, as they possessed a wide range of biological activities. This study explored the accumulations of F. suspensa metabolites by performing widely targeted metabolomic analysis. The metabolites were studied at four stages of fruit development. Metabolites in the fruits and leaves of F. suspensa during fruit development included phenolic acids, flavonoids, lipids, lignans and coumarins, amino acids and their derivatives, terpenes, organic acids, nucleotides and their derivatives, alkaloids, quinones, steroids, and tannins. Fourteen Forsythia related metabolites were detected. Their contents varied among the developmental stages. Statistically significant correlations were found between the levels of forsythoside B and 11-methyl-forsythide, and forsythialan B and phillygenin, in both leaves and fruits. According to the correlation analysis between metabolites, Forsythia related metabolites were divided into two classes and five subclasses. In total, 33 compounds presented significant correlations in both fruits and leaves, which indicated the potential relationship in the synthesis of Forsythia related metabolites. Forsythialan B and phillygenin were both negatively correlated with L-valine, while Z-6,7-epoxyligustilid was positively correlated with both compounds. The quality control compounds forsythiaside A and phillyrin were positively and negatively correlated with uracil, respectively. These metabolomics results may facilitate the biosynthesis of Forsythia related metabolites.
Identifiants
pubmed: 35763534
doi: 10.1371/journal.pone.0269915
pii: PONE-D-21-18670
pmc: PMC9239459
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0269915Déclaration de conflit d'intérêts
X.C. and Shijiazhuang Yiling Yiling Pharmaceutical Co,Ltd did not develop products and apply patents. X.C. does not hold a dissenting opinion as being a co-author in this study. Each co-author has no potentially competing interests occurred within 5 years of conducting the research under consideration, or preparing the article for publication.This does not alter our adherence to Plos One policies on sharing data and materials.
Références
Nat Commun. 2021 May 14;12(1):2828
pubmed: 33990581
Appl Environ Microbiol. 2007 Feb;73(4):1146-52
pubmed: 17158611
Neurochem Res. 2016 Apr;41(4):659-65
pubmed: 26498935
J Ethnopharmacol. 2017 Sep 14;209:236-247
pubmed: 28716571
Nature. 2020 Aug;584(7819):148-153
pubmed: 32699417
Int Immunopharmacol. 2015 Sep;28(1):494-9
pubmed: 26209933
J Chem Ecol. 1996 Nov;22(11):1987-99
pubmed: 24227211
Int Immunopharmacol. 2015 May;26(1):80-5
pubmed: 25797347
Exp Ther Med. 2014 Jan;7(1):179-184
pubmed: 24348786
J Neuroinflammation. 2020 Oct 15;17(1):305
pubmed: 33059746
Arch Pharm Res. 2016 Jul;39(7):998-1005
pubmed: 27323762
Yakugaku Zasshi. 2005 Feb;125(2):219-24
pubmed: 15684577
Neurochem Res. 2015 Jan;40(1):27-35
pubmed: 25344274
Rapid Commun Mass Spectrom. 2007;21(5):715-29
pubmed: 17279595
J Ethnopharmacol. 2016 Jul 1;187:49-56
pubmed: 27085937
Science. 2015 Sep 11;349(6253):1224-8
pubmed: 26359402
J Pharm Biomed Anal. 2007 Feb 19;43(3):1000-6
pubmed: 17156960
PLoS One. 2016 Oct 21;11(10):e0164805
pubmed: 27768772
J Pharm Pharmacol. 2008 Feb;60(2):261-6
pubmed: 18237475
Curr Med Chem. 2012;19(11):1682-705
pubmed: 22414089
J Exp Bot. 2015 Oct;66(20):6259-71
pubmed: 26163698
Molecules. 2015 May 29;20(6):10065-81
pubmed: 26035103
Int J Anal Chem. 2020 Jun 24;2020:8274193
pubmed: 32670374
Chin Med. 2015 Jul 02;10:16
pubmed: 26161134
Plant Cell Physiol. 2009 Dec;50(12):2200-9
pubmed: 19887541